London Daily

Focus on the big picture.
Thursday, Jul 10, 2025

UK launches seven-vaccine trial to test Covid jab booster shots

UK launches seven-vaccine trial to test Covid jab booster shots

Thousands of volunteers in the UK will be given a third dose of a Covid-19 vaccine as part of a large trial to provide experts with more information about the impact of booster jabs, Health Secretary Matt Hancock has announced.
Launched on Wednesday, the Cov-Boost study will see seven of the world's main jabs trialled on 2,886 patients and participants at 18 National Health Service (NHS) sites across the country.

University Hospital Southampton NHS Foundation Trust will lead the study, which is backed by £19.3 million ($27.3 million) of taxpayers' money.

Adults aged 30 and over will start receiving their additional dose of a vaccine from June, with preliminary results of the study expected in September.

"We will do everything we can to future-proof this country from pandemics and other threats to our health security," Hancock said in a statement on the project.

The health secretary said the study was the "first in the world" to provide data on patients' immune responses to third doses of Covid-19 vaccines.

However, research on the impact of third doses is already underway, including a study by Pfizer to analyse the effects of its Covid-19 vaccine on emerging variants of the virus.

In February, the US pharmaceutical giant and its German partner BioNTech announced they were studying the safety and the level of immune response of a third dose of their jointly-developed Covid jab against variants of the virus.

Around the same time, Pfizer's fellow US Covid-19 vaccine maker Moderna also announced it had begun giving volunteers third doses of its jab to study its efficacy against variants.

Both vaccines are set to be included in the UK trial, alongside those made by Oxford-AstraZeneca, Novavax, Valneva, Johnson & Johnson and Curevac.

Each volunteer will receive one booster dose, which may be of a different vaccine to that which they received as their previous shot.

The Novavax, Valneva and Curevac jabs will also be trialled at half-doses to see if this offers adequate protection and if it relieves recipients of any of the common side effects of vaccination.

Participants will be monitored throughout the study for side effects and will have their blood taken at four intervals within 12 months of vaccination to measure their immune responses.
Newsletter

Related Articles

0:00
0:00
Close
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
US Imposes New Tariffs on Brazilian Exports Amid Political Tensions
Azerbaijan and Armenia are on the brink of a historic peace deal.
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Weinstein Victim’s Lawyer Says MeToo Movement Still Strong
U.S. Enacts Sweeping Tax and Spending Legislation Amid Trade Policy Shifts
Football Mourns as Diogo Jota and Brother André Silva Laid to Rest in Portugal
Labour Expected to Withdraw Support for Special Needs Funding Model
Leaked Audio Reveals Tory Aide Defending DEI Record
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
London Stock Exchange Faces Historic Low in Initial Public Offerings
A new online platform has emerged in the United Kingdom, specifically targeting Muslim men seeking virgin brides
Trump Celebrates Independence Day with B-2 Flyover and Signs Controversial Legislation
Boris Johnson Urges Conservatives to Ignore Farage
SNP Ordered to Update Single-Sex Space Guidance Within Days
Starmer Set to Reject Calls for Wealth Taxes
Stolen Century-Old Rolls-Royce Recovered After Hotel Theft
Macron Presses Starmer to Recognise Palestinian State
Labour Delayed Palestine Action Ban Over Riot Concerns
Swinney’s Tax Comments ‘Offensive to Scots’, Say Tories
High Street Retailers to Enforce Bans on Serial Shoplifters
Music Banned by Henry VIII to Be Performed After 500 Years
Steve Coogan Says Working Class Is Being ‘Ethnically Cleansed’
Home Office Admits Uncertainty Over Visa Overstayer Numbers
JD Vance Questions Mandelson Over Reform Party’s Rising Popularity
Macron to Receive Windsor Carriage Ride in Royal Gesture
Labour Accused of ‘Hammering’ Scots During First Year in Power
BBC Head of Music Stood Down Amid Bob Vylan Controversy
Corbyn Eyes Hard-Left Challenge to Starmer’s Leadership
London Tube Trains Suspended After Major Fire Erupts Nearby
Richard Kemp: I Felt Safer in Israel Under Attack Than in the UK
Cyclist Says Police Cited Human Rights Act for Riding No-Handed
China’s Central Bank Consults European Peers on Low-Rate Strategies
AI Raises Alarms Over Long-Term Job Security
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Musk Battles to Protect Tesla Amid Trump Policy Threats
Air France-KLM Acquires Majority Stake in Scandinavian Airlines
UK Educators Sound Alarm on Declining Child Literacy
Shein Fined €40 Million in France Over Misleading Discounts
Brazil’s Lula Visits Kirchner During Argentina House Arrest
Trump Scores Legislative Win as House Passes Tax Reform Bill
Keir Starmer Faces Criticism After Rocky First Year in Power
DJI Launches Heavy-Duty Coaxial Quadcopter with 80 kg Lift Capacity
U.S. Senate Approves Major Legislation Dubbed the 'Big Beautiful Bill'
Largest Healthcare Fraud Takedown in U.S. History Announced by DOJ
×